March 2014

The recent National Disclosure Summit featured many practical seminars for compliance with the Physician Payments Sunshine Act.…

Deirdre Connelly, head of GlaxoSmithKline's (GSK) US pharmaceuticals business, announced that GSK will recruit doctors as in-house…

Recently, the FDA released a final rule amending its postmarket medical device reporting regulation (21 C.F.R. Part 803), to…

Registration for the Physician Payments Sunshine Act Registration opened for companies on February 18th, 2014. The Centers for…

March 17: The Centers for Medicare and Medicaid Services (CMS) issued a reminder that Open Payments Phase 1 ends on March 31. They…

The Accreditation Council for Continuing Medical Education (ACCME) hosted a webinar to discuss the recent changes to their…

FDA Commissioner Margaret Hamburg testified at the Senate Health, Education, Labor and Pensions (HELP) Committee, addressing…

The U.S. Department of Health & Human Services ("HHS") Office of Inspector General ("OIG") released its annual 2014 Work Plan.…

Researchers at the George Washington University School of Public Health and Health Services (SPHHS) found that pharmaceutical…

The U.S. recovered $4 billion last year through healthcare fraud prevention and enforcement efforts, according to a report…